Form 8-K - Current report:
SEC Accession No. 0001213900-21-059353
Filing Date
2021-11-15
Accepted
2021-11-15 16:08:59
Documents
14
Period of Report
2021-11-15
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea150464-8k_clene.htm   iXBRL 8-K 28758
2 PRESS RELEASE DATED NOVEMBER 15, 2021 ANNOUNCING COMPLETION OF PATIENT ENROLLMEN ea150464ex99-1_clene.htm EX-99.1 17213
  Complete submission text file 0001213900-21-059353.txt   271040

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE clnn-20211115.xsd EX-101.SCH 3816
4 XBRL DEFINITION FILE clnn-20211115_def.xml EX-101.DEF 26723
5 XBRL LABEL FILE clnn-20211115_lab.xml EX-101.LAB 36876
6 XBRL PRESENTATION FILE clnn-20211115_pre.xml EX-101.PRE 25341
7 EXTRACTED XBRL INSTANCE DOCUMENT ea150464-8k_clene_htm.xml XML 5613
Mailing Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121
Business Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121 801-676-9695
Clene Inc. (Filer) CIK: 0001822791 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39834 | Film No.: 211410556
SIC: 2834 Pharmaceutical Preparations